Sweden· SE-20120505000016
Vipidia 6,25 mg Filmdragerad tablett
A medicinal product containing alogliptin, registered in Sweden by Takeda Pharma A/S.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Alogliptin
- Manufacturer
- Takeda Pharma A/S
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20120505000016
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alogliptin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainVIPIDIA 6,25 MG COMPRIMIDOS RECUBIERTOS CON PELICULATakeda Pharma A/S
- IcelandVipidiaTakeda Pharma A/S
- NetherlandsVipidia 6,25 mg filmomhulde tablettenTakeda Pharma A/S
- PolandVipidiaTakeda Pharma A/S
- United KingdomAlogliptin 12.5mg tabletsTakeda UK Ltd
- CanadaNESINATAKEDA CANADA INC
- ItalyVIPIDIA*28 cpr rivestite 12,5 mgTAKEDA PHARMA A/S
- Japanアログリプチン安息香酸塩帝人ファーマ
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Alogliptin Heumann
- United Kingdom (Northern Ireland) · Alogliptin Aspire Pharma, Alogliptin Torrent
- Iceland · Vipidia
- Liechtenstein · Vipidia
- Malta · Alogliptin Torrent
- Norway · Vipidia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2a5b5c4e-0cce-4109-84ff-31e1bde626c7 GET /v1/drugs/2a5b5c4e-0cce-4109-84ff-31e1bde626c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20120505000016",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20120505000016",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/vipidia"
}See everything about alogliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.